Skyepharma Production SAS is a specialist CDMO that specializes in formulating, developing, and producing complex oral dosage forms with customized modified release profiles. The company offers a comprehensive range of services, from early-stage development to industrial manufacturing and packaging. With a skilled scientific team and patented technologies, Skyepharma has a proven record of successful development, reformulation and transfer projects. It offers solutions for the development, manufacturing and packaging of classic and complex oral solid dosage forms. Its GMP facility located in France is approved by the USFDA and ANVISA.
KEY SERVICES
Market Place
